 8. Known hypersensitivity to drugs with a similar biochemical structure to REP 2139-Mg or REP 2165-Mg e.g. other phosphorothioate oligonucleotides or Pegasys e.g. other interferons, Zadaxin or Viread e.g. other nucleoside analog polymerase inhibitors such as entecavir. 